Novartis announced that the U.S. Food and Drug Administration (FDA) has approved Gilenya (fingolimod) for the treatment of children and adolescents 10 to less than 18 years of age with relapsing forms of multiple sclerosis, making it the first disease-modifying therapy indicated for these patients.
NACDS today sent the following memo to chain members: We are writing to update you on President Trump’s announcement today regarding prescription drug pricing policies, and anticipated future events related to it.
CVS Health and Walgreens have commended President Trump for vowing in a speech today to fight high drug prices.
A Lewis Drug location in Sioux Falls, SD, on Monday, May 7, 2018, made possible the screening of approximately 170 patients for skin cancer – the highest number of screenings in the nearly 20-year history of the “Melanoma Monday” event.
Metro Inc. has completed its $4.5 billion ($3.6 billion U.S.) acquisition of the Jean Coutu Group, creating a food and drug retailer with more than 1,300 stores in Quebec, Ontario and New Brunswick.
PANTHERx Specialty Pharmacy has been selected by Otsuka America Pharmaceutical, Inc. to distribute Jynarque (tolvaptan), the only FDA-approved therapy for patients diagnosed with autosomal dominant polycystic kidney disease (ADPKD).
PARIS –L’Oréal Paris announces Amber Heard as its new global spokesperson. The company describes her as fearless, witty and smart, defying definition, rejecting convention as well as a committed woman who is making her voice heard.
Pepsi announced its summer plans as part of this year’s global creative campaign, Pepsi Generations, celebrating the brand’s iconic role in music history.
Express Scripts released new data today showing significantly improved clinical outcomes and lower drug spending for patients with complex, high-cost conditions who are enrolled in a suite of technology-supported, value-based SafeGuardRx programs.
Actifio has announced details of how its platform has sped database recovery times by 96% and cut storage costs by 60% at Apotex, the largest Canadian-owned generic pharmaceutical company.
Omnicell announced that Sentara RMH Medical Center, part of Sentara Healthcare in Virginia and northeastern North Carolina, has chosen to enhance control, efficiency and safety of its medication management processes with Omnicell’s newest central pharmacy automation, part of the company’s industry-
Diplomat Pharmacy Inc. announced that its board of directors has appointed Brian Griffin, executive vice president and chief executive officer of IngenioRx, the pharmacy benefit manager (PBM) of Anthem, as chief executive officer and chairman of the board of directors, effective June 4.
VALHALLA, N.Y.– Fujifilm Corp. has announced a global partnership and a global tour sponsorship with singer, songwriter, musician, producer and 10-time Grammy award-winner Taylor Swift for its instax series of instant cameras.
The Asembia 2018 Specialty Pharmacy Summit set a new attendance record with over 6,500 attendees last week at the Wynn and Encore here. This is the thirteenth consecutive attendance record set by Asembia, reflecting the growth in specialty pharmacy.
